Ipratropium Bromide Nasal Solution (0.03%) is indicated for the symptomatic relief of rhinorrhea (runny nose) associated with allergic and nonallergic perennial rhinitis.
With a revenue potential of ₹350-400 crore, the project would be launched in the early part of FY26.
The stock has gained a total of 28% in the last one year, and 0.79% gain in the last one month.
Top losers in Sensex include Zomato (-5.17%), Power Grid Corp (-3.05%), Tata Motors (-2.62%), Adani ports (-2.24%), and Titan Company (-2.72%).
The company’s operating EBITDA stood at ₹127 Crore, up by 5.30% y-o-y, over ₹120.60 Crore in the previous corresponding period.
As per the reported property consultants, the company has issued a global mandate for selecting candidates for the said land deal.
EBITDA margin increased significantly to 26.8%, while in Q3 FY24 it was 22.5%.
The revenues of the quarter were at ₹4,850.6 crore for the same period last year, which is up by 13.9% YoY to ₹5,526.9 crore this time around with the general business steady in growth.
Here are some of the stocks that may see significant price movement today.
At the close, the Sensex fell 0.7% (548 points) to 77,311.80, while the Nifty50 dropped 0.76% (178.35 points) to 23,381.60.

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.